Results for
""Dermatan Sulfate""[mesh_terms]

Profound Impact of Decline in N-Acetylgalactosamine-4-Sulfatase (Arylsulfatase B) on Molecular Pathophysiology and Human Diseases.

Joanne K Tobacman, Sumit Bhattacharyya

International journal of molecular sciences 2022;23(21):13146

Heparin-induced thrombocytopenia and thrombosis.

Matthew Bong, Vipul P Patel, Paul E Di Cesare

American journal of orthopedics (Belle Mead, N.J.) 2007;36(5):255-60

Chemistry and Function of Glycosaminoglycans in the Nervous System.

Nancy B Schwartz, Miriam S Domowicz

Advances in neurobiology 2022;29():117-162

Does deficiency of arylsulfatase B have a role in cystic fibrosis?

Joanne K Tobacman

Chest 2003;123(6):2130-9

Anticoagulation with recombinant hirudin and danaparoid sodium in pediatric patients.

Anton H Sutor, Barbara Zieger, Thomas Severin

Seminars in thrombosis and hemostasis 2003;28(5):447-54

Pharmacokinetic studies of dalteparin (Fragmin), enoxaparin (Clexane), and danaparoid sodium (Orgaran) in stable chronic hemodialysis patients.

Kevan R Polkinghorne, Lawrence P McMahon, Gavin J Becker

American journal of kidney diseases : the official journal of the National Kidney Foundation 2002;40(5):990-5

Heparin-induced thrombocytopenia: a frequent complication after cardiac surgery.

C Pouplard, S Regina, M-A May, Y Gruel

Archives des maladies du coeur et des vaisseaux 2007;100(6-7):563-8

In vitro cross-reactivity of danaparoid sodium in patients with heparin-induced thrombocytopenia type II undergoing cardiovascular surgery.

A Koster, O Meyer, H Hausmann, H Kuppe, R Hetzer, F Mertzlufft

Journal of clinical anesthesia 2000;12(4):324-7

Identification of the active site of DS-epimerase 1 and requirement of N-glycosylation for enzyme function.

David R Goodlett, Lars Malmström, Anders Malmström, Benny Pacheco, Marco Maccarana

The Journal of biological chemistry 2009;284(3):1741-7

Prospective randomised open-label comparison of danaparoid with dextran 70 in the treatment of heparin-induced thrombocytopaenia with thrombosis: a clinical outcome study.

B H Chong, A S Gallus, J F Cade, H Magnani, A Manoharan, M Oldmeadow, C Arthur, K Rickard, J Gallo, J Lloyd, P Seshadri, C N Chesterman

Thrombosis and haemostasis 2003;86(5):1170-5

Danaparoid: a review of its use in thromboembolic and coagulation disorders.

Tim Ibbotson, Caroline M Perry

Drugs 2003;62(15):2283-314

Anticoagulation in continuous renal replacement therapy.

O Vargas Hein, W J Kox, C Spies

Contributions to nephrology 2004;144():308-16

Argatroban: for a few selected patients.

Prescrire international 2013;22(135):33-5

Two dermatan sulfate epimerases form iduronic acid domains in dermatan sulfate.

Anders Malmström, Marco Maccarana, Benny Pacheco

The Journal of biological chemistry 2009;284(15):9788-95

The laboratory diagnosis and clinical management of patients with heparin-induced thrombocytopenia: an update.

Margaret Prechel, Jeanine M Walenga

Seminars in thrombosis and hemostasis 2008;34(1):86-96